The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Tuberculosis: Current situation, challenges and overview of its control programs in India
Open accessAbstract
Tuberculosis (TB) is one of the most ancient diseases of mankind, with molecular evidence going back to over 17,000 years. In spite of newer modalities for diagnosis and treatment of TB, unfortunately, people are still suffering, and worldwide it is among the top 10 killer infectious diseases, second only to HIV. According to World Health Organization (WHO), TB is a worldwide pandemic. It is a leading cause of death among HIV-infected people. In India, historically speaking, fight against TB can be broadly classified into three periods: early period, before the discoveries of x-ray and chemotherapy; post-independence period, during which nationwide TB control programs were initiated and implemented; and the current period, during which the ongoing WHO-assisted TB control program is in place. Today, India's DOTS (directly observed treatment-short course) program is the fastest-expanding and the largest program in the world in terms of patients initiated on treatment; and the second largest, in terms of population coverage. Major challenges to control TB in India include poor primary health-care infrastructure in rural areas of many states; unregulated private health care leading to widespread irrational use of first-line and second-line anti-TB drugs; spreading HIV infection; lack of political will; and, above all, corrupt administration. Multidrug-resistant TB (MDR-TB) is another emerging threat to TB eradication and is a result of deficient or deteriorating TB control program. WHO with its "STOP TB" strategy has given a vision to eliminate TB as a public health problem from the face of this earth by 2050. For this review article, data available at the official websites of WHO; and from the Ministry of Health, Government of India, were consulted, and search engines PubMed(®) and Google Scholar(®) were used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Hershkovitz, I., Donoghue, H. D., Minnikin, D. E., Besra, G. S., Lee, O. Y.-C., Gernaey, A. M., Galili, E., Eshed, V., Greenblatt, C. L., Lemma, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003426 · Cited by 506
Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study
Bate, R., Coticelli, P., Tren, R., & Attaran, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002132 · Cited by 161
Cited by
Green and Sustainable Solvents of the Future: Deep Eutectic Solvents
Prabhune, A., & Dey, R. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.121676 · Cited by 500
Gene silencing by CRISPR interference in mycobacteria
Choudhary, E., Thakur, P., Pareek, M., & Agarwal, N. (2015) · Nature Communications · doi:10.1038/ncomms7267 · Cited by 255
Bediang, G., Stoll, B., Elia, N., Abena, J.-L., Nolna, D., Chastonay, P., & Geissbuhler, A. (2014) · Trials · doi:10.1186/1745-6215-15-35 · Cited by 41
Long‐term exposure to indoor air pollution and risk of tuberculosis
Patel, V., Foster, A., Salem, A., Kumar, A., Kumar, V., Biswas, B., Mirsaeidi, M., & Kumar, N. (2021) · Indoor Air · doi:10.1111/ina.12756 · Cited by 27
Metadata
- Authors
- Sandhu, G.
- Venue
- Journal of Global Infectious Diseases
- Publisher
- Medknow
- Published
- 2011
- Volume
- 3
- Issue
- 2
- Pages
- 143
- ISSN
- 0974-777X (ISSN-L)
- OpenAlex
- W1992818587
- Cited by
- 245
- References
- 3
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tuberculosis: Current situation, challenges and overview of its control programs in India. https://app.cochat.ai/papers/10.4103/0974-777x.81691
- The paper
- Sandhu, G. (2011). Tuberculosis: Current situation, challenges and overview of its control programs in India. Journal of Global Infectious Diseases. https://doi.org/10.4103/0974-777x.81691
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.